Cons Less transparent pricing
1 The findings showed: Those not taking GLP-1 medications showed significantly more MS disease progression Higher risk of brainstem dysfunction (4.36% risk difference) Higher risk of cerebellar dysfunction (4.54% risk difference) Higher risk of bowel and bladder dysfunction (4.98% risk difference) As a retrospective analysis, this study has limitations including potential confounding factors, and definitive randomised controlled trials are needed to confirm any disease-modifying effects of GLP-1 medications in MS
However, they provide some preliminary compelling data suggesting future randomized trials are warranted
Ozempic, Wegovy, Mounjaro, and Zepbound are medications commonly used for weight management and diabetes, but they differ in their composition and focus
These formulas are commonly used by individuals looking to support recovery from physical stress, promote gut integrity, and maintain overall wellness through scientifically developed compounds